Prof. Leonardo Scapozza
Prof. Leonardo Scapozza is a pharmacist by training and received his PhD in pharmaceutical chemistry at the ETH.
​
He spent 3 years as postdoctoral fellow in Switzerland and in the USA (Texas A&M University) working in the field of pharmaceutical chemistry and structural biology. 1996 he returned at the ETHZ as “Oberassistent“ in Pharmaceutical Chemistry by Prof. Folkers where he became Assistant Professor in February 2001. In October 2004 he was appointed Full Professor of Pharmaceutical Biochemistry/Chemistry at the University of Geneva.
​
​
His research focuses on molecular recognition for a better understanding of ligand-macromolecule interactions to develop therapeutic strategies in the therapeutic area of Cancer, Antibiotics and Neglected/Orphan Diseases involving new chemical entities and targets. The approach is based on the combination of biochemistry/biophysics, medicinal chemistry and computational chemistry/molecular modelling techniques.
He is a member of the editorial board of a number of scientific journals, has won three Phoenix prizes for innovative scientific work in pharmaceutical chemistry, published more than 140 papers in peer-reviewed journals and is an inventor on 9 patents and an orphan drug designation on the use of tamoxifen in Duchenne muscular dystrophy granted by EMA in 2017. He is a member of the UNIGE SNF commission and a member of the board of the Swiss Society of Experimental Pharmacology (SSEP) as well as the Division of Medicinal Chemistry and Chemical Biology (DMCCB) of the Swiss Chemistry Society (SCS).
​
A full list of my publications can be found here:
​
